FDA Clearance Tracker · N970012-S177
AMS 700 Implantable Penile Prosthesis (IPP) with and without Inhibizone Treatment
Last checked: Nov 20, 2026Latest source record: May 20, 2020 (this decision)Source: openFDAMethods & limitations
Decided
May 20, 2020
Approved
Time to decision
30 days
Received Apr 20, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- N970012-S177
- Device name
- AMS 700 Implantable Penile Prosthesis (IPP) with and without Inhibizone Treatment
- Applicant
- Boston Scientific Corp
- Applicant location
- Marlboro, MA
- Received
- Apr 20, 2020
- Decided
- May 20, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- N970012
Device type
- Device type
- Prosthesis, penis, inflatable (JCW)
- Device class
- Class III
- Regulation
- 21 CFR 876.3350
- Specialty
- GI, Urology & Nephrology
FDA's approval statement
As written in FDA's record.
Approval for a site change from the BSC Minnetonka, MN facility to the BSC St. Paul, Minnesota facility.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.